Home / Generic availability / Desmopressin
When will generic Desmopressin be available?
Based on the patents and exclusivity the FDA lists today, generic desmopressin cannot be marketed in the United States before 2044-04-03, when the last listed protection expires.
Patents listed with the FDA
9 unexpired or current listing(s).
| Patent | Expires | Covers | Product |
|---|---|---|---|
| 11020448 | 2029-05-21 | method of use | NOCDURNA |
| 11963995 | 2029-05-21 | method of use | NOCDURNA |
| 10137167 | 2029-05-21 | method of use | NOCDURNA |
| 9974826 | 2030-04-13 | method of use | NOCDURNA |
| 11419914 | 2030-06-15 | method of use | NOCTIVA |
| 12090190 | 2030-06-15 | drug product | NOCTIVA |
| 9539302 | 2030-06-15 | drug product | NOCTIVA |
| 12214010 | 2044-04-03 | drug product | DESMODA |
| 12343372 | 2044-04-03 | drug product | DESMODA |
Approved products
| Product | Type | Applicant | Approved | |
|---|---|---|---|---|
| DDAVP, DDAVP (NEEDS NO REFRIGERATION) | Brand (NDA) | FERRING PHARMACEUTICALS INC | 1989-02-06 | reference listed drug |
| DDAVP | Brand (NDA) | J MOLNER HOLDINGS INC | 1984-03-30 | reference listed drug, reference standard |
| CONCENTRAID | Brand (NDA) | FERRING PHARMACEUTICALS INC | 1990-12-26 | |
| DDAVP | Brand (NDA) | FERRING PHARMACEUTICALS INC | 1995-09-06 | reference listed drug, reference standard |
| STIMATE, STIMATE (NEEDS NO REFRIGERATION) | Brand (NDA) | FERRING PHARMACEUTICALS INC | 1994-03-07 | reference listed drug |
| MINIRIN | Brand (NDA) | FERRING PHARMACEUTICALS INC | 2002-09-16 | reference listed drug |
| DESMOPRESSIN ACETATE | Brand (NDA) | FERRING PHARMACEUTICALS INC | 2008-05-08 | |
| NOCDURNA | Brand (NDA) | FERRING PHARMACEUTICALS INC | 2018-06-21 | reference listed drug |
| DESMOPRESSIN ACETATE PRESERVATIVE FREE | Generic (ANDA) | BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC | 2000-02-18 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | BEDFORD LABORATORIES DIV BEN VENUE LABORATORIES INC | 2000-02-18 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | BAUSCH HEALTH US LLC | 1999-01-25 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | MEITHEAL PHARMACEUTICALS INC | 1997-10-15 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | HOSPIRA INC | 2000-08-28 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | ACTAVIS LABORATORIES FL INC | 2005-07-01 | |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | Generic (ANDA) | APOTEX INC | 2005-01-27 | reference standard |
| DESMOPRESSIN ACETATE | Generic (ANDA) | IMPAX LABORATORIES INC | 2006-01-25 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | SUN PHARMACEUTICAL INDUSTRIES LTD | 2012-04-12 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | APOTEX INC | 2006-03-07 | |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | Generic (ANDA) | SUN PHARMACEUTICAL INDUSTRIES LTD | 2013-12-23 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | SUN PHARMACEUTICAL INDUSTRIES LTD | 2013-01-25 | |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | Generic (ANDA) | ZYDUS PHARMACEUTICALS USA INC | 2017-10-03 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | AMERICAN REGENT INC | 2019-02-14 | |
| DESMOPRESSIN ACETATE | Generic (ANDA) | NATCO PHARMA USA LLC | 2014-06-27 | |
| NOCTIVA | Brand (NDA) | ACERUS PHARMACEUTICALS USA LLC | 2017-03-03 | reference listed drug |
Frequently asked questions
When will generic Desmopressin be available?
Based on the patents and exclusivity the FDA lists today, generic desmopressin cannot be marketed in the United States before 2044-04-03, when the last listed protection expires.
Does this date guarantee a generic launches then?
No. It is the date the last protection the FDA currently lists expires. Patents can be challenged, licensed, or designed around, which can bring a generic earlier, and new patents can be listed later. Treat it as the outer limit of the brand's protection, not a launch forecast.
What is the difference between a patent and exclusivity?
A patent is granted by the patent office and listed with the FDA by the brand. Exclusivity is granted by the FDA itself on approval. They run independently, and exclusivity can keep a generic off the market even after a patent has expired.
What is a tentative approval?
It means the FDA has reviewed a generic application and judged it acceptable, but cannot allow it to be marketed yet because patents or exclusivity are still running. It is the clearest signal that a generic is ready to launch once the dates clear.
Source: FDA Orange Book via openFDA, with tentative-approval data from Drugs@FDA. Last updated 2026-09-23. Do not rely on this page to make decisions regarding medical care; always speak to your health provider about the risks and benefits of FDA-regulated products.